Wednesday, 26 August 2026European Markets

MYHOTELMATCH Stock Bullish By 28% In The Last 21 Sessions

Loading stream...

(vianews) - shares of myhotelmatch (cac 40: mhm.pa) rose by a staggering 28.21% in 21 sessions from €0.02 to €0.02 at 04:06 est on thursday, following the last session's downward trend. cac 40 is dropping 0.13% to €7,299.26, after four sequential sessions in a row of losses.

myhotelmatch's last close was €0.02, 39.05% under its 52-week high of €0.03.

about myhotelmatch

myhotelmatch s.a. engages in the development and exploitation of an online hotel reservation platform based on artificial intelligence (ai). it operates as an online travel agency based on the principle of online dating. the company, through its platform, connect a traveler and hotels with online hotel services whose profiles match. the company is based in biot, france.

volume

today's last reported volume for myhotelmatch is 951701 which is 171.24% above its average volume of 343223.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, myhotelmatch's stock is considered to be oversold (<=20).

more news about myhotelmatch (mhm.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com